| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property, plant and equipment, net | 40,614 | |||
| Inventories, net | 50,575 | |||
| Prepaid expenses and other current assets | 5,165 | |||
| Cash | 10,941 | |||
| Trade accounts receivable, net of allowance for expected credit losses of xxx and 384, respectively | 32,322 | |||
| Total current assets | 99,003 | |||
| Goodwill | 45,406 | |||
| Other intangible assets, net | 23,839 | |||
| Other noncurrent assets | 4,411 | |||
| Deferred income taxes, net | 7,688 | |||
| Total assets | 220,961 | |||
| Treasury stock - at cost 4,436,114 shares at june 30, 2025 and 4,436,114 shares at december 31, 2024 | 21,492 | |||
| Accumulated deficit | -31,698 | |||
| Preferred stock par value .10 per share authorized 1,000,000 shares none issued | 0 | |||
| Common stock par value .10 per share authorized 40,000,000 shares issued 21,078,446 shares at june 30, 2025 and 21,069,079 shares at december 31, 2024 outstanding 16,642,332 shares at june 30, 2025 and 16,632,965 shares at december 31, 2024 | 2,108 | |||
| Capital in excess of par value | 192,350 | |||
| Accumulated other comprehensive loss | -2,820 | |||
| Total ultralife corporation equity | 138,448 | |||
| Non-controlling interest | 197 | |||
| Total stockholders equity | 138,645 | |||
| Accrued expenses and other current liabilities | 8,757 | |||
| Current portion of long-term debt | 3,438 | |||
| Accrued compensation and related benefits | 2,674 | |||
| Accounts payable | 15,029 | |||
| Total current liabilities | 29,898 | |||
| Other noncurrent liabilities | 3,508 | |||
| Long-term debt, net | 47,510 | |||
| Deferred income taxes | 1,400 | |||
| Total liabilities | 82,316 | |||
| Total liabilities and stockholders equity | 220,961 | |||
ULTRALIFE CORP (ULBI)
ULTRALIFE CORP (ULBI)